Mereo BioPharma and Oncologie enter into global licensing agreement for Navicixizumab
Mereo BioPharma Group plc (NASDAQ:¬†MREO, AIM: MPH), "Mereo" or the "Company," and Oncologie, Inc. ("Oncologie")…
Ben (Reactive)13/01/2020











